Brooklyn Investment Group bought a new position in Albemarle Co. (NYSE:ALB – Free Report) in the third quarter, according to its most recent disclosure with the SEC. The firm bought 1,499 shares of the specialty chemicals company’s stock, valued at approximately $142,000.
Other hedge funds and other institutional investors have also modified their holdings of the company. Primecap Management Co. CA increased its position in shares of Albemarle by 0.5% during the 3rd quarter. Primecap Management Co. CA now owns 3,833,984 shares of the specialty chemicals company’s stock worth $363,117,000 after purchasing an additional 20,930 shares during the last quarter. ProShare Advisors LLC increased its position in shares of Albemarle by 10.2% during the 2nd quarter. ProShare Advisors LLC now owns 1,568,602 shares of the specialty chemicals company’s stock worth $149,833,000 after purchasing an additional 144,705 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Albemarle by 2.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,311,331 shares of the specialty chemicals company’s stock valued at $125,264,000 after acquiring an additional 29,721 shares during the period. Earnest Partners LLC boosted its holdings in Albemarle by 11.9% during the 2nd quarter. Earnest Partners LLC now owns 1,198,730 shares of the specialty chemicals company’s stock valued at $114,503,000 after acquiring an additional 127,615 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Albemarle by 38.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,020,590 shares of the specialty chemicals company’s stock valued at $96,660,000 after acquiring an additional 282,194 shares during the period. 92.87% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of equities analysts recently commented on the company. Scotiabank lowered their target price on Albemarle from $135.00 to $85.00 and set a “sector perform” rating for the company in a report on Tuesday, August 6th. KeyCorp lowered their target price on Albemarle from $132.00 to $127.00 and set an “overweight” rating for the company in a report on Tuesday, November 12th. Baird R W cut Albemarle from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 5th. Piper Sandler decreased their price objective on Albemarle from $95.00 to $90.00 and set an “underweight” rating for the company in a research note on Thursday, August 8th. Finally, JPMorgan Chase & Co. decreased their price objective on Albemarle from $115.00 to $78.00 and set a “neutral” rating for the company in a research note on Monday, August 19th. One investment analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $114.47.
Albemarle Trading Up 1.1 %
ALB opened at $107.95 on Thursday. The firm has a market cap of $12.69 billion, a price-to-earnings ratio of -6.44 and a beta of 1.55. Albemarle Co. has a 52 week low of $71.97 and a 52 week high of $153.54. The business’s 50 day moving average is $98.58 and its two-hundred day moving average is $98.69. The company has a quick ratio of 1.58, a current ratio of 2.44 and a debt-to-equity ratio of 0.43.
Albemarle Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Thursday, January 2nd. Shareholders of record on Friday, December 13th will be given a dividend of $0.405 per share. This represents a $1.62 annualized dividend and a yield of 1.50%. The ex-dividend date of this dividend is Friday, December 13th. Albemarle’s dividend payout ratio (DPR) is -9.67%.
Albemarle Profile
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
Featured Articles
- Five stocks we like better than Albemarle
- How to Use the MarketBeat Stock Screener
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Where Do I Find 52-Week Highs and Lows?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What Are Trending Stocks? Trending Stocks Explained
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALB – Free Report).
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.